Extremities Archer™ Shoulder Systems Presented, Catalyst OrthoScience Showcasing Innovative Products at Upcoming Orthopedic Events byChris StewartDecember 13, 2021
Extremities Financial Recon Top Stories Medical device firm reels in $12M investment byJosh SandbergOctober 11, 2021
Recon Catalyst OrthoScience Gains Momentum As It Introduces The Archer™ R1 Reverse Shoulder System And Rebrands Its Archer™ CSR Total Shoulder System byChris StewartApril 28, 2021
Recon Regulatory Sports Medicine Catalyst OrthoScience receives FDA 510(K) clearance of its reverse shoulder system byChris StewartMarch 17, 2021
Extremities Recon Newly Published Study With the Stemless Catalyst CSR™ Total Shoulder System Demonstrates Good Results in Adult Arthroplasty Patients of All Ages at 2-3 Year Follow-Up byJosh SandbergFebruary 18, 2021
Recon William N. Levine, MD to Present Catalyst CSR™ Total Shoulder System at American Shoulder and Elbow Surgeons 2019 Annual Meeting byJosh SandbergOctober 17, 2019
Extremities Financial Catalyst OrthoScience Closes $12.7 Million Oversubscribed Financing Round to Fuel Growth of Novel Total Shoulder System byJosh SandbergMay 14, 2019
Extremities Regulatory Catalyst OrthoScience Announces 510(k) Clearance for Uncemented Press Fit Humeral Component During the 2019 AAOS Annual Meeting byJosh SandbergMarch 13, 2019
Recon Catalyst OrthoScience Introduces 3-Peg Glenoid To Its Catalyst CSR™ Total Shoulder System byJosh SandbergOctober 11, 2018
Recon Catalyst OrthoScience Adds Brian K. Hutchison to Board of Directors as Executive Chair, Interim CEO byJosh SandbergJune 28, 2018
